Stereotactic Radiation Therapy in Treating Patients With Brain Metastases

Completed · Phase 2

Conditions studied: Metastatic Cancer

In brief

RATIONALE: Stereotactic radiation therapy may be able to deliver x-rays directly to the tumor and cause less damage to normal tissue. PURPOSE: Phase II trial to study the effectiveness of stereotactic radiation therapy in treating patients who have brain metastases.

Key facts

Study ID

NCT00006259

Run by

Case Comprehensive Cancer Center

People needed

10

Starts

2000-01-01

Expected to finish

2005-02-01

Last updated by the study team

2020-07-27

Who can join

Age: 18 and older, up to 120. Sex: any. Healthy volunteers: not accepted.

Where it is running

• Ireland Cancer Center at University Hospitals Case Medical Center, Case Comprehensive Cancer Center — Cleveland, Ohio, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.